Events

European Conference on EDGE AI Technologies and Applications
OCT
Mon
20
OCT
Tue
21
OCT
Wed
22

Starts in 1 month from now

Location

Naples (Italy)

Hotel San Francesco al Monte
Corso Vittorio Emanuele, 328, 80135 Naples, Italy
Programmes
Digital, Industry & Space AI Continent Semiconductors

The EEAI 2025 conference brings together representatives from academia, researchers, and industry practitioners to exchange the latest fundamental advances in the state of the art and practice of edge AI technologies and applications, identify emerging research topics, and define the future of edge AI research and innovation. 

The conference is co-organised by a number of Horizon Europe projects. For more information on the event, and to register, please visit the event website.

Please note that this is a paying event!

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.